.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers are currently investigating Nifuroxazide Hepatocellular Carcinoma therapy to improve outcomes in advanced liver cancer. Hepatocellular carcinoma (HCC) often resists standard treatments due to an immunosuppressive microenvironment. Recently, a study introduced a biomimetic delivery system using macrophage-like cells. They loaded Nifuroxazide (NFX) into RAW264.7 cells to create a platform called Mφ-NFX. This innovative strategy effectively overcomes the drug's poor solubility. Furthermore, the macrophage carriers deliver the agent directly to tumor tissues without causing systemic toxicity.
Notably, Nifuroxazide acts as a potent inhibitor of STAT3 signaling. This inhibition is crucial because aberrant STAT3 activation drives chemoresistance in many tumors. Additionally, the macrophage delivery system reprograms the tumor microenvironment. It specifically promotes the polarization of macrophages toward the tumor-killing M1 phenotype. Consequently, the M1/M2 ratio increases, which actively suppresses tumor growth. This dual action significantly enhances the overall therapeutic effect in preclinical models.
Moreover, the combination of Mφ-NFX and Oxaliplatin demonstrates remarkable synergy. Mechanistically, this treatment inhibits the AKT/β-catenin signaling pathway. Therefore, this approach suppresses tumor progression more effectively than using oxaliplatin alone. Importantly, the macrophage-based platform shows high biocompatibility and target specificity. This finding suggests a promising future for using biomimetic drug delivery systems in clinical hepatology. Ultimately, this platform offers a path to sensitize resistant tumors to conventional chemotherapy.
Nifuroxazide inhibits the STAT3 signaling pathway. This inhibition reduces tumor growth, prevents immune evasion, and helps overcome resistance to drugs like oxaliplatin.
Nifuroxazide has poor oral solubility and low bioavailability. Using macrophages as biomimetic carriers ensures the drug is delivered directly to the tumor site, improving efficacy while minimizing side effects.
The combination synergistically inhibits the AKT/β-catenin pathway. This action prevents cancer cell proliferation and promotes a more active immune response within the tumor microenvironment.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Yang Z et al. Macrophage-delivered Nifuroxazide reprograms immunosuppressive microenvironment and synergizes with oxaliplatin for enhanced anti-hepatocellular carcinoma therapy. J Nanobiotechnology. 2026 Feb 23. doi: 10.1186/s12951-026-04196-6. PMID: 41731511.
Li K et al. Regorafenib and Nifuroxazide exert enhanced suppression of hepatocellular carcinoma by inhibiting STAT3 and immune remodeling. J Cancer Res Clin Oncol. 2024.
Morelli M et al. Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition. MDPI. 2023.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers developed a biomimetic macrophage delivery system for Nifuroxazide to reprogram the tumor microenvironment and improve outcomes in liver cancer....
5 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
